Dis-Chem Pharmacies Limited reported revenue results for the period from 1 September 2022 to 5 February 2023. For the period, the company recorded group revenue growth (excluding vaccines and COVID-19 related lines) of 8.7% compared to the corresponding period in the prior year ("corresponding period").
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.53 ZAR | -0.30% | -0.27% | +9.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.25% | 1.59B | |
-36.12% | 15.37B | |
-27.24% | 12.7B | |
-26.65% | 6.89B | |
-6.57% | 6.26B | |
+15.31% | 6.2B | |
+75.54% | 4.96B | |
-2.34% | 4.63B | |
-8.67% | 3.98B | |
-10.64% | 3.56B |
- Stock Market
- Equities
- DCP Stock
- News Dis-Chem Pharmacies Limited
- Dis-Chem Pharmacies Limited Reports Revenue Results for the Period from 1 September 2022 to 5 February 2023